Bristol-Myers shares fall after it withdraws FDA application for combo lung cancer treatment

Indonesia Berita Berita

Bristol-Myers shares fall after it withdraws FDA application for combo lung cancer treatment
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 CNBC
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 72%

The New York-based pharmaceutical giant said it pulled its applications for a combination of its immunotherapy drugs Opdivo and Yervoy after recent discussions with the FDA.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

CNBC /  🏆 12. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

FDA promises 'threat' to vaping if companies continue marketing to youthFDA promises 'threat' to vaping if companies continue marketing to youthFDA issues threat to vaping if companies continue marketing to youth
Baca lebih lajut »

Promising new drug for aggressive stage IV breast cancer encounters setbackPromising new drug for aggressive stage IV breast cancer encounters setbackPromising new drug for aggressive stage IV breast cancer delayed by FDA.
Baca lebih lajut »

FDA chief threatens to take e-cigarettes off the marketFDA chief threatens to take e-cigarettes off the marketFDA commissioner made his most direct threat yet against e-cigarette companies, saying they face an “existential threat” if they don’t stop marketing to youth.
Baca lebih lajut »



Render Time: 2025-04-03 01:51:53